Technology News and Research

RSS

FDA grants orphan drug designation for Avedro's VibeX to treat Keratoconus

Avedro, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's VibeX for use with its KXL System (UVA irradiation) for Corneal Cross-linking to treat Keratoconus.

12 Sep 2011

New treatment strategy for dominant forms of muscular dystrophy

Investigators at The Research Institute at Nationwide Children's Hospital are studying a potential new treatment strategy for dominant forms of muscular dystrophy, thanks to preliminary funding from The Ohio State University Center for Clinical and Translational Science.

12 Sep 2011

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

PharmAthene, Inc. announced today that it has achieved significant progress in the development of its second generation anthrax vaccine, SparVax.

12 Sep 2011

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Nektar Therapeutics announced today that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California.

12 Sep 2011

Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

"Acquired drug resistance" (ADR) is a major problem encountered in treating some forms of cancer. The ability to monitor the proteins involved in drug resistance has been a hurdle facing cancer researchers. However, a team of researchers at Moffitt Cancer Center, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of ADR and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.

9 Sep 2011

Ultrasonic neuromodulation can be quickly applied in neurocritical care situations

The discovery that low-intensity, pulsed ultrasound can be used to noninvasively stimulate intact brain circuits holds promise for engineering rapid-response medical devices.

9 Sep 2011

NYC REACH selects Criterions EHR as partner company

NYC REACH, the Regional Extension Center overseen by the Primary Care Information Project at the NYC Health Department, has selected the Criterions EHR as a partner company. The NYC REACH program is designed to assist metropolitan practices with the adoption of EHR technology and the achievement of government Meaningful Use incentives.

9 Sep 2011

Einstein led consortium to spearhead Central Africa International Epidemiologic Databases to Evaluate AIDS

In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.

9 Sep 2011

Duties, role of clinical laboratory microbiologists could change significantly in the future

With the increasing availability of sophisticated technologies to rapidly diagnose and treat infectious diseases, the duties and the role of clinical laboratory microbiologists, who traditionally perform these tests, could see significant changes in the next few years. That is one of the conclusions of a series of reports published in a special supplement to the September 2011 Journal of Clinical Microbiology.

9 Sep 2011

Mary Ann Liebert launches Games for Health Industry Insider

Mary Ann Liebert, Inc., publishers announces the launch of Games for Health Industry Insider , a new bi-weekly electronic newsletter offering up-to-the-minute industry news on health games-an emerging and increasingly adopted resource for healthcare.

9 Sep 2011

Aura's NanoSmart platform can enable earlier detection, treatment of cancers

Aura Biosciences, Inc., a biotech company focused on the development of nano-enabled drug delivery systems, has completed several pre-clinical research programs. The resulting data suggest that Aura's NanoSmart platform can enable earlier detection of cancers and distant metastases; and then provide precisely targeted treatment of those cancers.

9 Sep 2011

Simple universal test to detect Alzheimer’s early

A ten-minute memory test that gives early warning of Alzheimer’s in people as young as 50 is being piloted in GP surgeries. Using a touch-screen computer or an iPad, it can distinguish between normal forgetfulness and the more dangerous memory lapses that signal dementia in its earliest stages. If trials are successful, it could be in widespread use in under a year. The developer, Cambridge Cognition, said the mobile electronic test will allow GPs to access patients presenting memory problems more quickly, simply and accurately than with tradition paper-based tests.

8 Sep 2011

Angioslide introduces new 5x300mm PROTEUS device for treating Superficial Femoral Artery

Angioslide Ltd. announces the first procedures with its new 5x300mm PROTEUS device for treating the Superficial Femoral Artery. PROTEUS technology combines a Percutaneous Transluminal Angioplasty balloon and embolic capture of particles in one device. The new 5x300 mm size joins Angioslide's current dedicated product line solutions for the lower limbs.

8 Sep 2011

MRG reports 6.5% annual growth in the US and European endoscope market through 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the overall United States and European endoscope market will show a sustained growth averaging 6.5 percent per year through 2015, primarily driven by strong growth in the large GI endoscope segment, but also seeing notable growth in cameras.

From Evident Corporation - Life Sciences 8 Sep 2011

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Nexera Medical, Inc., today announced plans to submit to the U.S. Food and Drug Administration amended antimicrobial claims for its current 510(k) clearance for the SpectraShield 9500 Surgical N95 Respirator with embedded antimicrobial technology. The expanded antimicrobial claims will be supported by test data on the inactivation performance of certain strains of viruses.

8 Sep 2011

HRSA announces $5.1M in awards as part of Ryan White HIV/AIDS Program

The Health Resources and Services Administration (HRSA) today announced awards of $5.1 million to provide training and technical assistance (TA) as part of the Ryan White HIV/AIDS Program, which provides HIV-related services in the United States for those who do not have sufficient health care coverage or financial resources for coping with HIV disease.

8 Sep 2011

Smith & Nephew launches DYONICS PLATINUM Series Shaver Blades for arthroscopy procedures

Smith & Nephew today announced the launch of its innovative, single-use DYONICS PLATINUM Series Shaver Blades which deliver superior arthroscopic resection, debris evacuation and sharpness.

8 Sep 2011

Study: Almost one third of students in Uganda have been subject to sexual coercion

Almost one third of students at a university in Uganda say that they have been subject to sexual coercion, an experience which was often linked to risky sexual behaviour. This is shown in a study from Lund University in Sweden.

8 Sep 2011

Enrollment complete in Concentric Medical's Stentriever trial for acute ischemic stroke

Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced completion of enrollment of the TREVO Study.

8 Sep 2011

OptiNose chooses BioClinica's advanced imaging and IWR solutions for clinical trials

BioClinica, Inc., a global provider of clinical trial management solutions, today announced that OptiNose, Inc. selected BioClinica Trident IWR, Optimizer clinical supplies forecasting, and Imaging Core Lab services for use in a series of clinical trials including several pivotal Phase III studies.

From Clario 8 Sep 2011

Technology News and Research

FDA grants orphan drug designation for Avedro's VibeX to treat Keratoconus

New treatment strategy for dominant forms of muscular dystrophy

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

Nektar announces positive results from NKTR-102 Phase 2 study on metastatic breast cancer

Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

Ultrasonic neuromodulation can be quickly applied in neurocritical care situations

NYC REACH selects Criterions EHR as partner company

Einstein led consortium to spearhead Central Africa International Epidemiologic Databases to Evaluate AIDS

Duties, role of clinical laboratory microbiologists could change significantly in the future

Mary Ann Liebert launches Games for Health Industry Insider

Aura's NanoSmart platform can enable earlier detection, treatment of cancers

Simple universal test to detect Alzheimer’s early

Angioslide introduces new 5x300mm PROTEUS device for treating Superficial Femoral Artery

MRG reports 6.5% annual growth in the US and European endoscope market through 2015

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

HRSA announces $5.1M in awards as part of Ryan White HIV/AIDS Program

Smith & Nephew launches DYONICS PLATINUM Series Shaver Blades for arthroscopy procedures

Study: Almost one third of students in Uganda have been subject to sexual coercion

Enrollment complete in Concentric Medical's Stentriever trial for acute ischemic stroke

OptiNose chooses BioClinica's advanced imaging and IWR solutions for clinical trials

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News